+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cystic Fibrosis Therapeutics - Global Strategic Business Report

  • PDF Icon

    Report

  • 282 Pages
  • July 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 1244803
The global market for Cystic Fibrosis Therapeutics is estimated at US$17.5 Billion in 2023 and is projected to reach US$46.8 Billion by 2030, growing at a CAGR of 15.1% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the cystic fibrosis therapeutics market is driven by several factors, including increasing awareness and diagnosis rates, advancements in genetic research, and significant investments in drug development. The rising prevalence of cystic fibrosis, particularly in developed countries, has led to greater demand for effective treatments. Improved diagnostic techniques, such as newborn screening and genetic testing, are enabling earlier detection and intervention, which are crucial for managing the disease. Moreover, the pharmaceutical industry`s robust pipeline of innovative therapies, supported by substantial funding from both public and private sectors, is accelerating the development and approval of new treatments. Collaboration between academic institutions, biotech companies, and patient advocacy groups is fostering a more dynamic and productive research environment. Additionally, regulatory incentives, such as orphan drug designations and expedited review processes, are encouraging the development of CF therapeutics. These factors collectively contribute to the expanding cystic fibrosis therapeutics market, offering hope for better management and potential cures for this challenging condition.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Cystic Fibrosis Medication segment, which is expected to reach US$42.1 Billion by 2030 with a CAGR of a 15.5%. The Cystic Fibrosis Treatment Devices segment is also set to grow at 13.0% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $4.5 Billion in 2023, and China, forecasted to grow at an impressive 19.8% CAGR to reach $12.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Cystic Fibrosis Therapeutics Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Cystic Fibrosis Therapeutics Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Cystic Fibrosis Therapeutics Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as AbbVie Inc., Galapagos NV, Genentech, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 56 Featured):

  • AbbVie Inc.
  • Galapagos NV
  • Genentech
  • Gilead Sciences Inc.
  • Novartis AG
  • Vertex Pharmaceuticals Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Global Economic Update
  • Cystic Fibrosis Therapeutics - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Cystic Fibrosis Spurs Growth
  • Advances in Genetic Research Propel Market Expansion
  • Improved Diagnostic Techniques Drive Early Detection and Treatment
  • Increasing Awareness Campaigns Throw the Spotlight on Cystic Fibrosis
  • Advancements in Gene Therapy Techniques Propel Growth
  • Improved Drug Delivery Methods Generate Opportunities for Enhanced Treatments
  • Newborn Screening Programs Drive Adoption of Early Intervention Strategies
  • Personalized Medicine Trends Spur Growth in Targeted Therapies
  • Chronic Inflammation Management Technologies Propel Market Expansion
  • Mucus Clearance Innovations Generate Demand for Respiratory Function Improvement
  • Technological Innovations in CRISPR/Cas9 Editing Create New Treatment Possibilities
  • Adoption of Inhalation Therapies Strengthens the Business Case for Non-Invasive Treatments
  • Economic Burden of CF Prompts Demand for Cost-Effective Therapies
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Cystic Fibrosis Therapeutics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 3: World Historic Review for Cystic Fibrosis Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 4: World 16-Year Perspective for Cystic Fibrosis Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 6: World Historic Review for Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 7: World 16-Year Perspective for Medication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Other Treatment Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for Other Treatment Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for Other Treatment Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for Hospital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 18: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 19: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 21: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 22: World 16-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 23: USA Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 24: USA Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 25: USA 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2024 & 2030
  • Table 26: USA Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: USA Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 28: USA 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
CANADA
  • Table 29: Canada Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 30: Canada Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 31: Canada 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2024 & 2030
  • Table 32: Canada Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 33: Canada Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 34: Canada 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
JAPAN
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 35: Japan Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 36: Japan Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 37: Japan 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2024 & 2030
  • Table 38: Japan Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: Japan Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 40: Japan 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
CHINA
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 41: China Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 42: China Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 43: China 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2024 & 2030
  • Table 44: China Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: China Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 46: China 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
EUROPE
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 47: Europe Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 48: Europe Historic Review for Cystic Fibrosis Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 49: Europe 16-Year Perspective for Cystic Fibrosis Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: Europe Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 52: Europe 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2024 & 2030
  • Table 53: Europe Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 54: Europe Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 55: Europe 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
FRANCE
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 56: France Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: France Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 58: France 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2024 & 2030
  • Table 59: France Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 60: France Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 61: France 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
GERMANY
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 62: Germany Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 63: Germany Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 64: Germany 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2024 & 2030
  • Table 65: Germany Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 66: Germany Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 67: Germany 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
ITALY
  • Table 68: Italy Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 69: Italy Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 70: Italy 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2024 & 2030
  • Table 71: Italy Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 72: Italy Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 73: Italy 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 74: UK Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 75: UK Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 76: UK 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2024 & 2030
  • Table 77: UK Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 78: UK Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 79: UK 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
SPAIN
  • Table 80: Spain Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 81: Spain Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 82: Spain 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2024 & 2030
  • Table 83: Spain Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 84: Spain Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 85: Spain 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
RUSSIA
  • Table 86: Russia Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 87: Russia Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 88: Russia 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2024 & 2030
  • Table 89: Russia Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 90: Russia Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 91: Russia 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 93: Rest of Europe Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 94: Rest of Europe 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2024 & 2030
  • Table 95: Rest of Europe Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 96: Rest of Europe Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 97: Rest of Europe 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 99: Asia-Pacific Historic Review for Cystic Fibrosis Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 100: Asia-Pacific 16-Year Perspective for Cystic Fibrosis Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 102: Asia-Pacific Historic Review for Cystic Fibrosis Therapeutics by Treatment Method - Medication, Devices and Other Treatment Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 103: Asia-Pacific 16-Year Perspective for Cystic Fibrosis Therapeutics by Treatment Method - Percentage Breakdown of Value Sales for Medication, Devices and Other Treatment Methods for the Years 2014, 2024 & 2030
  • Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 105: Asia-Pacific Historic Review for Cystic Fibrosis Therapeutics by Distribution Channel - Hospital, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 106: Asia-Pacific 16-Year Perspective for Cystic Fibrosis Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2024 & 2030
AUSTRALIA
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Cystic Fibrosis Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Galapagos NV
  • Genentech
  • Gilead Sciences Inc.
  • Novartis AG
  • Vertex Pharmaceuticals Inc.

Table Information